Prothena (PRTA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual General Meeting scheduled for May 14, 2026, in Dublin, Ireland, with voting available online or in person.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two directors, Shane M. Cooke and Dennis J. Selkoe, to serve until the 2029 AGM unless earlier disqualified.
Ratification of KPMG LLP as independent auditor for fiscal year 2026, with audit committee authorized to set remuneration.
Advisory vote on executive compensation for named executive officers.
Provision for other business to be transacted as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and auditor ratification.
Latest events from Prothena
- Returned to profitability in H1 2026 on milestone revenue and lower expenses, with cash guidance revised lower.PRTA
Q2 2026 - Late-stage pipeline and partnerships position for major milestones and multi-billion royalties.PRTA
Corporate presentation - Advancing late-stage neurodegenerative programs and pioneering CYTOPE for undruggable targets.PRTA
The Citizens Life Sciences Conference 2026 - Late-stage pipeline and strong partnerships drive major milestones and value creation.PRTA
Corporate presentation - Returned to profitability in Q1 2026 with $32.7M net income and strong cash reserves.PRTA
Q1 2026 - Director elections, auditor ratification, and executive pay are key focus areas, with strong governance oversight.PRTA
Proxy filing - Advancing late-stage neuro and amyloid therapies with major milestones and strong partnerships.PRTA
Corporate presentation - Advanced late-stage pipeline, strong cash, and 2026 milestone potential drive outlook.PRTA
Q4 2025 - Restructuring and pipeline progress set up major clinical and financial milestones for 2026.PRTA
Cantor Global Healthcare Conference 2025